The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being ...

Improvements in health care in Eswatini have relied for years on Pepper and the generosity of the American people. During the ...

Staffers at the remnants of the United States Agency for International Development (USAID), the foreign aid agency dismantled ...

In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

Drugmaker Gilead Sciences is not only providing the shot in the US, but is also working with governments and health groups in the UK and low-income countries to make these products more available.

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Since then, scientists have made astonishing progress in their understanding of AIDS and its underlying ... more than one in five new HIV infections — 22 percent. Drug users who became infected ...

Adam Hall, 42, faces multiple charges including rape and deliberate HIV transmission, and is set to appear at Newcastle Crown Court on July 2.

"I would single out aspirin from all the other [drugs of its class]," Benet says. Stone and Greenberg note that aspirin is having a revival. It fights inflammation, a process at the core of heart ...